180 related articles for article (PubMed ID: 7033607)
1. [Administration of angiotensin I converting enzyme inhibitor captopril, in a case of renal crisis of scleroderma--the effects of captopril to the temperature of the skin lesion in scleroderma (author's transl)].
Gotoh S; Ogihara T; Hata T; Maruyama A; Naka T; Nakamaru M; Mikami H; Masuo K; Kumahara Y
Nihon Jinzo Gakkai Shi; 1981 Aug; 23(8):1133-41. PubMed ID: 7033607
[No Abstract] [Full Text] [Related]
2. Clinical course of patients with scleroderma renal crisis treated with captopril.
Zawada ET; Clements PJ; Furst DA; Bloomer HA; Paulus HE; Maxwell MH
Nephron; 1981; 27(2):74-8. PubMed ID: 7022235
[TBL] [Abstract][Full Text] [Related]
3. Renin-angiotensin system in normotensive and hypertensive patients with progressive systemic sclerosis: hyporesponsiveness of renin during captopril test.
Guillevin L; Leenhardt A; Godeau P
Postgrad Med J; 1983; 59 Suppl 3():171-2. PubMed ID: 6359107
[No Abstract] [Full Text] [Related]
4. Captopril in the treatment of scleroderma renal crisis.
Thurm RH; Alexander JC
Arch Intern Med; 1984 Apr; 144(4):733-5. PubMed ID: 6370160
[TBL] [Abstract][Full Text] [Related]
5. [A case of bilateral renovascular hypertension controlled by angiotensin converting enzyme inhibitor (captopril) after arterioplasty for predominantly stenotic side (author's transl)].
Sakoda H; Ohashi H; Yoshida H; Morimoto K; Kawai C; Hara A; Matsunaga M; Kawamura J; Kumada K
Nihon Jinzo Gakkai Shi; 1982 Feb; 24(2):167-73. PubMed ID: 7047823
[No Abstract] [Full Text] [Related]
6. [Beneficial effect of the converting enzyme inhibitor on the acute renal failure of scleroderma with arterial hypertension].
Mercatello A; Zech PY
Nouv Presse Med; 1981 Apr; 10(19):1596. PubMed ID: 7025853
[No Abstract] [Full Text] [Related]
7. [Treatment of the hypertensive crisis by blocking the renin-angiotensin system (author's transl)].
Wambach G; Kaufmann W
MMW Munch Med Wochenschr; 1982 Jul; 124(27):638-40. PubMed ID: 6810156
[No Abstract] [Full Text] [Related]
8. [Acute effects of angiotensin I converting enzyme inhibitor, captopril (SQ 14, 225) on severe heart failure--hemodynamics, plasma catecholamine levels, renin-angiotensin-aldosterone system and blood gas data (author's transl)].
Morimoto Y; Baba M; Takahashi T; Fujii M; Konishi T; Kawanami C; Hamada M; Nakano T; Takezawa H
Kokyu To Junkan; 1982 Mar; 30(3):317-25. PubMed ID: 6808624
[No Abstract] [Full Text] [Related]
9. Reversal of scleroderma renal crisis for more than two years in a patient treated with captopril.
Sorensen LB; Paunicka K; Harris M
Arthritis Rheum; 1983 Jun; 26(6):797-801. PubMed ID: 6344871
[No Abstract] [Full Text] [Related]
10. [Successful treatment of renal hypertension in a 2 1/2-year-old girl with the converting enzyme inhibitor captopril (author's transl)].
Lütkenhaus C; Bonzel K; Diekmann L; Koch H
Monatsschr Kinderheilkd; 1980 Nov; 128(11):724-6. PubMed ID: 6110181
[TBL] [Abstract][Full Text] [Related]
11. [Effects of angiotensin converting enzyme inhibitor SQ 14,225 on the blood pressure, renin-angiotensin-aldosterone system and renal function in patients with malignant hypertension (author's transl)].
Shionoiri H; Uneda S; Tochikubo O; Ohonishi T; Harada J; Sesoko S; Goto E; Fujishima S; Kaneko Y
Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):13-22. PubMed ID: 6247528
[No Abstract] [Full Text] [Related]
12. Failure of captopril to reverse the renal crisis of scleroderma.
Brown EA; Macgregor GA; Maini RN
Ann Rheum Dis; 1983 Feb; 42(1):52-3. PubMed ID: 6338841
[TBL] [Abstract][Full Text] [Related]
13. [Clinical experience with an oral angiotensin I-converting enzyme inhibitor in hypertensive patients: effects on blood pressure and the renin-aldosterone system by a single dose (author's transl)].
Mizuno K; Shigetomi S; Haruyama K; Matsui J; Gotho M; Fukuchi S
Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):1-11. PubMed ID: 6247526
[No Abstract] [Full Text] [Related]
14. [Treatment of severe arterial hypertension with captopril (SQ 14.225) (author's transl)].
Di Giulio S; Perez-Ramirez JL; Jamoun P; Grünfeld JP; Meyer P
Nouv Presse Med; 1981 Apr; 10(19):1551-5. PubMed ID: 6269557
[TBL] [Abstract][Full Text] [Related]
15. [Scleroderma complicated by arterial hypertension and renal insufficiency. Favorable effects of captopril].
Grünfeld JP; Pulik M; Reveillaud RJ; Martinet C
Nouv Presse Med; 1980 Oct; 9(36):2658. PubMed ID: 7001352
[No Abstract] [Full Text] [Related]
16. Deterioration of renal function in hypertensive patients with scleroderma despite blood pressure normalization with captopril.
Waeber B; Schaller MD; Wauters JP; Brunner HR
Klin Wochenschr; 1984 Aug; 62(15):728-30. PubMed ID: 6387262
[TBL] [Abstract][Full Text] [Related]
17. [Successful use of angiotensin II receptor antagonist (losartan) in a patient with scleroderma renal crisis].
Hasegawa S; Iesato K; Tsukahara T; Yamamoto S; Kondou Y; Ogawa M; Ueda S
Nihon Jinzo Gakkai Shi; 2000 Feb; 42(2):60-5. PubMed ID: 10771577
[TBL] [Abstract][Full Text] [Related]
18. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A
Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
[TBL] [Abstract][Full Text] [Related]
19. [Inhibition of the angiotensin I converting enzyme with SQ-14225 (captopril) in the medical treatment of severe renovascular hypertension].
Martínez Amenós A; Caralps A; Rama H; Sarrias X; Alsina J
Rev Clin Esp; 1981 Sep; 162(6):265-8. PubMed ID: 7036249
[No Abstract] [Full Text] [Related]
20. [Blood concentration and urinary excretion of captopril (SQ 14,255), angiotensin converting enzyme activity and R-A-A system after administration of captopril--in patients with chronic renal failure compared with essential hypertension].
Miyazaki N; Shionoiri H; Uneda S; Yasuda G; Gotoh E; Fujishima S; Kaneko Y; Kawahara Y; Yamazaki Y
Nihon Jinzo Gakkai Shi; 1982 Apr; 24(4):421-8. PubMed ID: 6750186
[No Abstract] [Full Text] [Related]
[Next] [New Search]
